Typhoid vaccine(Emergent BioSolutions/Prokarium)

伤寒疫苗（Emergent BioSolutions / Prokarium）

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTyphoid vaccine(Emergent BioSolutions/Prokarium)
Drug Alias NameTyphellaM-01ZH09MICRO-TY
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTyphoid Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmergent
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oxford
Inactive CompaniesEmergent Biosolutions Inc
Active IndicationsTyphoid Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A